WMJ Vol 123 Issue 6: Association Between Lead Poisoning and Third-Grade Academic Performance of Children in Milwaukee 

ABSTRACT 

Introduction: Lead-poisoned children with blood lead levels (BLL) of > 5 μg/dL among those tested in Milwaukee, Wisconsin, increased from 8.6% to 10.4% between 2014 and 2016. We examined the association between lead poisoning and academic performance of third-grade children in Milwaukee. 

Methods: Data from Milwaukee Public Schools, birth certificates, and the City of Milwaukee Health Department on third-grade students from 2010 through 2015 were analyzed. The outcome was academic performance measured as standardized math and reading scores. The key independent variable was elevated BLL ≥ 5 μg/dL. Standardized reading and math test scores were modeled using mixed effects linear regression, including a school-specific random intercept and repeated effects for school trimesters using an autoregressive correlation structure of first order. The association of reading scores with lead exposure was explored after adjusting for school year, trimester, child, and maternal characteristics. 

Results: Of 18,213 children with available lead testing data, the median maximum BLL was 4.0 μg/dL (interquartile range 34.0-6.1). Nearly 60% (58.3%) had maximum BLLs < 5 μg/dL, 27.7% had maximum BLLs of 5-9 μg/dL, 11.0% had maximum BLLs of 10-19 μg/dL, and 3.0% had maximum BLL ≥20 μg/dL. After controlling for potential confounders, children with BLLs ≥20 μg/dL, 10-19 μg/dL, and 5-9 μg/dL, respectively, had lower standardized math and reading scores when compared to children with BLLs <5 μg/dL at P < 0.001. 

Conclusions: Even at low levels, childhood lead poisoning persists in Milwaukee and is associated with lower third-grade academic performance in standardized reading and math tests. Parent education, childhood lead testing, and home lead abatement are critical strategies to improve children’s educational performance. 

Intended Audience

The intended audience for this continuing education activity is healthcare professionals caring for the people of Wisconsin and beyond.

Learning Objectives

As a result of participating in this journal-based activity, healthcare team members will be able to:    

  1. Identify lead exposure risks in pediatric patients.
  2. Explain the association between blood lead levels and academic performance of third-grade children.
  3. Discuss how healthcare teams can engage in lead poisoning prevention strategies.
Course summary
Available credit: 
  • 1.00 AAPA Category 1 CME
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Registration opens: 
10/28/2025
Course expires: 
10/27/2026
Cost:
$0.00
Rating: 
0

FACULTY DISCLOSURE

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the  speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.

For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.

Name of IndividualIndividual's Role in ActivityFinancial Relationship DisclosureDiscussion of Unlabeled/Unapproved Uses of Drugs/Devices
Marianna Shershneva, MD, PhDAccreditation SpecialistNo relevant relationships with ineligible companies to disclose    No
James Eberhard, MFAAccreditation SpecialistNo relevant relationships with ineligible companies to disclose    No
Ronald Anguzu, MD, MPH, PhDAuthorNo relevant relationships with ineligible companies to disclose    No
Lisa E. Rein, MSAuthorNo relevant relationships with ineligible companies to disclose    No
Sergey Tarima, PhDAuthorNo relevant relationships with ineligible companies to disclose    No
Melanie Stewart, PhDAuthorNo relevant relationships with ineligible companies to disclose    No
Constance Kostelac, PhDAuthorNo relevant relationships with ineligible companies to disclose    No
Catherine Carter, MPHAuthorNo relevant relationships with ineligible companies to disclose    No
John R. Meurer, MD, MBAAuthorNo relevant relationships with ineligible companies to disclose    No
Laura D. Cassidy, MS, PhDAuthorNo relevant relationships with ineligible companies to disclose    No
Ayanna Vasquez, MD, MSReviewerNo relevant relationships with ineligible companies to disclose    No
Megan Yanny, MDReviewerNo relevant relationships with ineligible companies to disclose    No
Mary Ingle, PhD, MPHReviewerNo relevant relationships with ineligible companies to disclose    No
Fahad Aziz, MDEditorNo relevant relationships with ineligible companies to disclose    No
Jennifer Esch, PharmD, MBA, BCPSReviewerNo relevant relationships with ineligible companies to disclose    No
Jessica Leiberg, DNP, ACNPReviewerNo relevant relationships with ineligible companies to disclose    No

*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.

The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.

Discloser List CME Internal Report
Accreditation LogosAccreditation Statements
In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison ICEP and the Wisconsin Medical Journal.  The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

 

American Medical Association (AMA)

The University of Wisconsin–Madison ICEP designates this journal-based CE activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

American Nurses Credentialing Center (ANCC)

The University of Wisconsin–Madison ICEP designates this journal-based CE activity for a maximum of 1.0 ANCC contact hour.  

American Academy of Physician Assistants (AAPA)

The University of Wisconsin–Madison ICEP has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until 10/27/2026. PAs should only claim credit commensurate with the extent of their participation.

 

Continuing Education Units

The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.

Available Credit

  • 1.00 AAPA Category 1 CME
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™

Cost:
$0.00
Please login or register to take this course.

Accessibility

If you need anything to participate in this program, please contact [email protected].

Required Hardware/software

Free, current version of Chrome, Firefox, Safari, or Edge. Some older browsers and Microsoft Internet Explorer could produce error messages or not display the content correctly. 

Free, current version of Adobe Acrobat Reader or other .pdf reader.